Phosphorylation sites in the cerebral cavernous malformations complex

Journal of Cell Science

Volumn 124, Issue 23, 2011, Pages 3929-3932

  Kim, Jaehong ^a,c   Sherman, Nicholas E ^b   Fox, Jay W ^b   Ginsberg, Mark H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Division of Translational Research   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA1 INTEGRIN; BINDING PROTEIN; CCM1 PROTEIN; CCM2 PROTEIN; CCM3 PROTEIN; CEREBRAL CAVERNOUS MALFORMATION MULTIPROTEIN COMPLEX; ICAP1 ALPHA PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 3; MULTIPROTEIN COMPLEX; RAC1 PROTEIN; SERINE; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MACROPHAGE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; STOICHIOMETRY;

AMINO ACID SEQUENCE; BINDING SITES; CARRIER PROTEINS; CELL LINE, TUMOR; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; PLASMIDS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS; TRANSFECTION;

EID: 84863161750     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.095471     Document Type: Article

References (34)

1. Akers, A. L., Johnson, E., Steinberg, G. K., Zabramski, J. M. and Marchuk, D. A. (2008). Biallelic somatic and germline mutations in cerebral cavernous malformations (CCM): evidence for a two-hit mechanism of CCM pathogenesis. Hum. Mol. Genet. 18, 919-930.
2. Amanchy, R., Periaswamy, B., Mathivanan, S., Reddy, R., Tattikota, S. G. and Pandey, A. (2007). A curated compendium of phosphorylation motifs. Nat. Biotechnol. 25, 285-286.
3. Beraud-Dufour, S., Gautier, R., Albiges-Rizo, C., Chardin, P. and Faurobert, E. (2007). Krit 1 interactions with microtubules and membranes are regulated by Rap1 and integrin cytoplasmic domain associated protein-1. FEBS J. 274, 5518-5532.
4. Bergametti, F., Denier, C., Labauge, P., Arnoult, M., Boetto, S., Clanet, M., Coubes, P., Echenne, B., Ibrahim, R., Irthum, B. et al. (2005). Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 76, 42-51.
5. Boulday, G., Blecon, A., Petit, N., Chareyre, F., Garcia, L. A., Niwa-Kawakita, M., Giovannini, M. and Tournier-Lasserve, E. (2009). Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis. Model. Mech. 2, 168-177.
6. Bouvard, D. and Block, M. R. (1998). Calcium/calmodulin-dependent protein kinase II controls integrin alpha5beta1-mediated cell adhesion through the integrin cytoplasmic domain associated protein-1alpha. Biochem. Biophys. Res. Commun. 252, 46-50.
7. Crose, L. E., Hilder, T. L., Sciaky, N. and Johnson, G. L. (2009). Cerebral cavernous malformation 2 protein promotes Smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells. J. Biol. Chem. 284, 13301-13305.
8. Denier, C., Goutagny, S., Labauge, P., Krivosic, V., Arnoult, M., Cousin, A., Benabid, A., Comoy, J., Frerebeau, P., Gilbert, B. et al. (2004). Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 74, 326-337.
9. Francalanci, F., Avolio, M., De Luca, E., Longo, D., Menchise, V., Guazzi, P., Sgro, F., Marino, M., Goitre, L., Balzac, F. et al. (2009). Structural and functional differences between KRIT1A and KRIT1B isoforms: a framework for understanding CCM pathogenesis. Exp. Cell Res. 315, 285-303.
10. Glading, A. J. and Ginsberg, M. H. (2010). Rap1 and Its Effector, KRIT1/CCM1, Regulate β-catenin signaling. Dis. Model. Mech. 3, 78-83.
11. Glading, A., Han, J., Stockton, R. A. and Ginsberg, M. H. (2007). KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J. Cell Biol. 179, 247-254.
12. Goudreault, M., D'Ambrosio, L. M., Kean, M. J., Mullin, M. J., Larsen, B. G., Sanchez, A., Chaudhry, S., Chen, G. I., Sicheri, F., Nesvizhskii, A. I. et al. (2009). A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol. Cell. Proteomics 8, 157-171.
13. Guclu, B., Ozturk, A. K., Pricola, K. L., Bilguvar, K., Shin, D., O'Roak, B. J. and Gunel, M. (2005). Mutations in apoptosis-related gene, PDCD10, cause cerebral cavernous malformation 3. Neurosurgery 57, 1008-1013.
14. Hamada, K., Shimizu, T., Yonemura, S., Tsukita, S., Tsukita, S. and Hakoshima, T. (2003). Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-2 complex. EMBO J. 22, 502-514.
15. Harburger, D. S. and Calderwood, D. A. (2009). Integrin signalling at a glance. J. Cell Sci. 122, 159-163.
16. Kleaveland, B., Zheng, X., Liu, J. J., Blum, Y., Tung, J. J., Zou, Z., Sweeney, S. M., Chen, M., Guo, L., Lu, M. M. et al. (2009). Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat. Med. 15, 169-176.
17. Laberge-le Couteulx, S., Jung, H. H., Labauge, P., Houtteville, J. P., Lescoat, C., Cecillon, M., Marechal, E., Joutel, A., Bach, J. F. and Tournier-Lasserve, E. (1999). Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat. Genet. 23, 189-193.
18. Louvi, A., Chen, L., Two, A. M., Zhang, H., Min, W. and Gunel, M. (2011). Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc. Natl. Acad. Sci. USA 108, 3737-3742.
19. Mably, J. D., Mohideen, M. A., Burns, C. G., Chen, J. N. and Fishman, M. C. (2003). Heart of glass regulates the concentric growth of the heart in zebrafish. Curr. Biol. 13, 2138-2147.
20. Mably, J. D., Chuang, L. P., Serluca, F. C., Mohideen, M. A., Chen, J. N. and Fishman, M. C. (2006). Santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development 133, 3139-3146.
21. Pagenstecher, A., Stahl, S., Sure, U. and Felbor, U. (2009). A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum. Mol. Genet. 18, 911-918.
22. Serebriiskii, I., Estojak, J., Sonoda, G., Testa, J. R. and Golemis, E. A. (1997). Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 15, 1043-1049.
23. Stockton, R. A., Shenkar, R., Awad, I. A. and Ginsberg, M. H. (2010). Cerebral cavernous malformations proteins inhibit rho kinase to stabilize vascular integrity. J. Exp. Med. I207, 881-896.
24. Uhlik, M. T., Abell, A. N., Johnson, N. L., Sun, W., Cuevas, B. D., Lobel-Rice, K. E., Horne, E. A., Dell'Acqua, M. L. and Johnson, G. L. (2003). Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat. Cell Biol. 5, 1104-1110.
25. Voss, K., Stahl, S., Schleider, E., Ullrich, S., Nickel, J., Mueller, T. D. and Felbor, U. (2007). CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics 8, 249-256.
26. Whitehead, K. J., Plummer, N. W., Adams, J. A., Marchuk, D. A. and Li, D. Y. (2004). Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 131, 1437-1448.
27. Whitehead, K. J., Chan, A. C., Navankasattusas, S., Koh, W., London, N. R., Ling, J., Mayo, A. H., Drakos, S. G., Jones, C. A., Zhu, W. et al. (2009). The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat. Med. 15, 177-184.
28. Wohlgemuth, S., Kiel, C., Kramer, A., Serrano, L., Wittinghofer, F. and Herrmann, C. (2005). Recognizing and defining true Ras binding domains I: biochemical analysis. J. Mol. Biol. 348, 741-758.
29. Wustehube, J., Bartol, A., Liebler, S. S., Brutsch, R., Zhu, Y., Felbor, U., Sure, U., Augustin, H. G. and Fischer, A. (2010). Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc. Natl. Acad. Sci. USA 107, 12640-12645.
30. Xue, B., Wen, C., Shi, Y., Zhao, D. and Li, C. (2005). Human NRAGE disrupts E-cadherin/beta-catenin regulated homotypic cell-cell adhesion. Biochem. Biophys. Res. Commun. 336, 247-251.
31. Zawistowski, J. S., Serebriiskii, I. G., Lee, M. F., Golemis, E. A. and Marchuk, D. A. (2002). KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum. Mol. Genet. 11, 389-396.
32. Zawistowski, J. S., Stalheim, L., Uhlik, M. T., Abell, A. N., Ancrile, B. B., Johnson, G. L. and Marchuk, D. A. (2005a). CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum. Mol. Genet. 14, 2521-2531.
33. Zawistowski, J. S., Stalheim, L., Uhlik, M. T., Abell, A. N., Ancrile, B. B., Johnson, G. L. and Marchuk, D. A. (2005b). CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum. Mol. Genet. 14, 2521.
34. Zhang, J., Clatterbuck, R. E., Rigamonti, D., Chang, D. D. and Dietz, H. C. (2001). Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum. Mol. Genet. 10, 2953-2960.